Navigation Links
Miami HIV Clinic Administrator Pleads Guilty for Role in a $14 Million Medicare Fraud Scheme
Date:9/9/2008

WASHINGTON, Sept. 9 /PRNewswire-USNewswire/ -- Miami resident Dilcia Marinez, 57, pleaded guilty today to her role in defrauding the Medicare program and laundering the proceeds of the crimes in connection with a $14 million HIV infusion fraud scheme, Acting Assistant Attorney General Matthew Friedrich of the Criminal Division and U.S. Attorney R. Alexander Acosta of the Southern District of Florida announced.

Marinez pleaded guilty to conspiracy to commit health care fraud and conspiracy to commit money laundering before U.S. District Judge Federico Moreno in Miami. In her plea, Marinez admitted that she was the president and director of G&S Medical Center Inc. (G&S), a Miami health care clinic. Marinez admitted that she entered into an agreement in approximately May 2003 with Carlos Benitez, Luis Benitez, Thomas McKenzie and others to operate G&S as an HIV infusion clinic. According to information contained in plea documents, the Benitezes referred HIV-positive Medicare beneficiaries to the clinic and directed McKenzie to teach the clinic physicians ways to make it appear legitimate services were being provided.

Marinez also admitted that between approximately June 2003 and December 2003, G&S submitted approximately $14 million in claims to the Medicare program for HIV infusion services that were never provided and services that were medically unnecessary. According to information in the plea documents, Medicare paid approximately $9.6 million on the fraudulent claims. In addition, Marinez admitted to assisting the Benitez brothers in laundering approximately $4 million in proceeds from the fraud by making checks out to sham marketing and management companies owned and controlled by the Benitezes.

In a related case, brothers Carlos, Luis and Jose Benitez as well as McKenzie were indicted on June 11, 2008, for their role in a $110 million HIV infusion and money laundering scheme. The indictment alleges that the Benitez brothers were the
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Miami Jury Convicts Medical Company Owner of Medicare Fraud
2. Cogon Systems Supports the South Florida Health Information Initiatives 2nd Annual Health Information Exchange Summit - November 8th in Miami, FL
3. "High School Musicals" Corbin Bleu Joins Colgate-Palmolive, United Way and Miami-Dade Elementary School Students for Dental Health Challenge
4. Four Miami Health Care Company Owners Sentenced to 57 Months in Prison For Medicare Fraud
5. Nine Miami Defendants in Strike Force Cases Sentenced for $56.5 Million in Medicare Fraud
6. CyberKnife Centers of Miami, Palm Beach and Tampa Invited to Join M.D. Anderson Cancer Center Study
7. Miami Jury Convicts Physician and Three Business Owners of Medicare Fraud
8. Gentiva(R) Health Services to Present March 18th at Lehman Brothers Eleventh Annual Global Healthcare Conference in Miami
9. CRH Medical Corporation opens new Center in Miami, Florida
10. AT&T Announces Grant to Center on Aging-University of Miami Miller School of Medicine
11. Seven Miami-Area Residents Charged in $11 Million Medicare Fraud Scheme

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Award-winning author James...l-length book, Short White Coat: Lessons from Pati...th through the third year of medical school--the g...PHILADELPHIA, PA (PRWEB) December 2, 2009 -- Most...d themselves dressed in a tiny hospital gown or st...
(Date:12/2/2009)..., , SAN DIEGO, Dec. 2 /PRNewswire-FirstCall...present at the 21st Annual Piper Jaffray Health Ca... presentation is scheduled to be webcast live and ...ction of Gen-Probe,s website at www.gen-probe.com...wing the event. ,, About Gen-Probe ,, Gen...
(Date:12/2/2009)..., , JOHANNESBURG, Dec. 2 Le...(over US$6 million) investment in AllLife, the inn...g with HIV and diabetes. The investment brings tog...ent fund, and AllLife, one of Africa,s most innova...lace after World AIDS Day. ,, "AllLife has deve...
(Date:12/2/2009)...CHICAGO Results of a large-scale clinical trial p...ogical Society of North America (RSNA) provide the...reening ultrasound for women with dense breasts wh...ion, the study confirmed that MRI is highly sensit...d that annual screening with ultrasound in additio...
(Date:12/1/2009)..., , NEW YORK, Dec. 1 R...ch report is available in its catalogue: ,, Th...eutics - Market Forecasts to 2015, Competitive Ben..., http://www.reportlinker.com/p0166814/The-Futu...---Market-Forecasts-to-2015-Competitive-Benchmarki...
Breaking Medicine News(10 mins):Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 3Health News:Annual screening with breast ultrasound or MRI could benefit some women 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22
..., NEW YORK, March 23, 2008Research led by investi...MSKCC) has shown that therapeutic cloning, also kn...e used to treat Parkinsons disease in mice. The s...cloning or SCNT has been successfully used to trea...
...Music therapy can help reduce anxiety and improve ...ealthDay News) -- Almost everyone has used music a...nergized. But the discipline of music therapy take...in physical, psychological, social and cognitive d...
...Study with dogs shows devices much more than a mec...Y, March 21 (HealthDay News) -- In dogs with damag...rovements in tissue levels and the activity of a ...emical analysis of the biological effects a pacema...
...But it,s not too late to protect yourself and your...(HealthDay News) -- News from the diabetes front s... of the disease, fueled by obesity and sedentary l...adults and children, according to the American Dia...
..., (PHILADELPHIA) Scientists at the Center for Tra... in Philadelphia have shown that a specific signal... helping it to adapt during a heart attack. , The... or if it was actually causing more heart cells to...
...WASHINGTON, March 21 America,s Blood Centers,(ABC... community,independent blood centers, has teamed u... educate lawmakers about the importance of stem ce...laborate on emerging regulatory,issues, standards/...
Other Medicine News:Health News:Music as Medicine 2Health News:Music as Medicine 3Health News:Pacemakers Change Biology of the Heart 2Health News:Diabetes' Toll Continues to Grow 2Health News:Diabetes' Toll Continues to Grow 3Health News:Diabetes' Toll Continues to Grow 4Health News:Signaling protein helps limit damage in heart attack, Jefferson scientists show 2Health News:ABC and NMDP Partner to Meet Growing Need for Stem Cell and Cord Blood Transplants, Assure Funding for Cord Blood Network, Encourage Minority Donor Recruitment 2Health News:ABC and NMDP Partner to Meet Growing Need for Stem Cell and Cord Blood Transplants, Assure Funding for Cord Blood Network, Encourage Minority Donor Recruitment 3Health News:ABC and NMDP Partner to Meet Growing Need for Stem Cell and Cord Blood Transplants, Assure Funding for Cord Blood Network, Encourage Minority Donor Recruitment 4
(Date:12/1/2009)..., VIENNA, Va., Dec. 1 CE... oncology company and a developer of vaccines and ...nfectious diseases, announced today that it has re...esearch Organization (CRO) to run CEL-SCI,s upcomi...ad and neck cancer with the Company,s lead product...
(Date:12/1/2009)..., MORRISVILLE, N.C., Dec. 1 nCo... investigation of devices for minimally-invasive t... initiation of a feasibility clinical trial design...ed surgical and catheter procedure, the convergent...ysmal atrial fibrillation (AF). This prospective,...
(Date:12/1/2009)..., MT. LAUREL, N.J., Dec. 1 /PRNewswire-FirstCall...vider of technology-enabled clinical documentation...ch tool from Primordial Design, Inc. has been inte...real-time speech recognition system. The solution ...of North America (RSNA) convention November 29 thr...
Breaking Medicine Technology:CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 3nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2MedQuist Integrates Search Engine from Primordial with SpeechQ(TM) for Radiology 2Moores UCSD Cancer Center Luau 26 Longboard Invitational Celebrates 16 Years of Surfing for a Cure to Raise Funds for Cancer Research 52826 1Moores UCSD Cancer Center Luau 26 Longboard Invitational Celebrates 16 Years of Surfing for a Cure to Raise Funds for Cancer Research 52826 2Moores UCSD Cancer Center Luau 26 Longboard Invitational Celebrates 16 Years of Surfing for a Cure to Raise Funds for Cancer Research 52826 3Moores UCSD Cancer Center Luau 26 Longboard Invitational Celebrates 16 Years of Surfing for a Cure to Raise Funds for Cancer Research 52826 4Molecule plays early role in nonsmoking lung cancer 52821 1Molecule plays early role in nonsmoking lung cancer 52821 2121 breeding tigers estimated to be found in Nepal 9374 1121 breeding tigers estimated to be found in Nepal 9374 2
... pivotal studies presented at the National Lipid ...ions, PARSIPPANY, N.J., May 30 Daiichi Sankyo, I...es of three pivotal studies,demonstrated that the ...on,diabetes treatment regimens can lower A1C in pa...ter. The analyses included all patients receiving,...
... Increasingly Important Factor When Selecting Trea...s - ABSTRACT No: 5110 (Poster 6... the,largest oncology meeting in the world, the Am...that the costs of managing side effects in patient... with sunitinib (Sutent(R)),are two to three times...
Other Medicine Technology:Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 2Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 3Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 4Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 5Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 6Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon 2Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon 3
...r beam is delivered through an ultra thin flexible... freedom of movement when performing surgery. The...of handpieces. Handpieces are supplied with stand...d angled fiber guides with different lengths offer...
Reusable Components
VersaStep™ Reposable (Reusable Components - Standard Length)
VersaStep™ Reposable Short Single-Use Instruments
Medicine Products: